Dr. Surendera Tyagi

Group Chief Scientific Officer, Global Head of R&D

  • Appointed: 2018
  • Joined Hikma: 2018
  • Nationality: American

Skills and experience: Surendera joined Hikma in January 2018 as Group Chief Scientific Officer and Global Head of R&D. Surendera has oversight of Hikma’s global R&D function and is responsible for managing new products, technology, and platforms from conceptualisation to commercialisation.

Surendera has more than 20 years’ experience of technical and leadership experience in small and large pharmaceuticals companies. Surendera joined from Fresenius Kabi, where he led their US Innovation and Development Center and successfully expanded their oncology business. Surendera has also served as Chief Scientific Officer for Dabur Pharma and held scientific and regulatory roles at Roche, IGEN. Abbott/Hospira and Schwarz Pharma. 

Surendera holds a PhD in Chemistry from the University of Oklahoma and a Graduate Certificate in Regulatory and Quality from Purdue University.

Other appointments: None